PARP Inhibitor Lynparza Effective in Men with BRCAMutant Prostate Cancer

PARP Inhibitor - Lynparza Effective in Men with BRCA-Mutant Prostate Cancer

08:18 EDT 30 Jun 2019 | Cancer Connect

Men with prostate cancer have genomic defects that can be targeted with Lynparza and should undergo genomic testing.

More From BioPortfolio on "PARP Inhibitor - Lynparza Effective in Men with BRCA-Mutant Prostate Cancer"